Clinical testing should be individualized, not based on populations

J Clin Invest. 2019 Sep 3;129(9):3472-3473. doi: 10.1172/JCI130903.
No abstract available

Publication types

  • Review

MeSH terms

  • Biomarkers, Tumor* / blood
  • Biomarkers, Tumor* / genetics
  • Circulating Tumor DNA* / blood
  • Circulating Tumor DNA* / genetics
  • High-Throughput Nucleotide Sequencing*
  • Humans
  • Neoplasms* / blood
  • Neoplasms* / genetics
  • Precision Medicine*

Substances

  • Biomarkers, Tumor
  • Circulating Tumor DNA